Latest filing published 25 Jun 2018 for Bellerophon Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jens Luehring: trading record in brief
Jens Luehring discloses dealings in Bellerophon Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 19 February 2015 to 21 June 2018, the count stands at 6 filings.
On the market, this insider has only ever bought: 3 purchases, €3.8M in total. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants.
The record was last updated on 25 June 2018 with a share grant in Bellerophon Therapeutics, Inc. The last purchase on record was published on 3 October 2017, which is 3,324 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jens Luehring
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,555 shares0Common StockSEC:0001600132-18-000099:0
- 10,000 sharesCommon StockSEC:0001600132-17-000112:0Canonical exit: 28 Dec 2017 (T+90)
- 30,798 shares0Common StockSEC:0001600132-17-000067:0
- 20,000 shares@ US$0.56100.0% of flowCommon StockSEC:0001628280-16-021971:0Canonical exit: 9 Mar 2017 (T+90)
- 19,860 shares0Common StockSEC:0001600132-16-000047:0
5 of 5 declarations